198 related articles for article (PubMed ID: 6175458)
21. [beta2-Microglobulin and monoclonal gammapathies (author's transl)].
Belleville F; Bertrand F; Nabet P
Pathol Biol (Paris); 1978 Sep; 26(6):348-50. PubMed ID: 83581
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination.
Mavlight GM; Stuckey SE; Cabanillas FF; Keating MJ; Tourtellotte WW; Schold SC; Freireich EJ
N Engl J Med; 1980 Sep; 303(13):718-22. PubMed ID: 6157089
[TBL] [Abstract][Full Text] [Related]
23. [Beta 2-microglobulin in lymphoproliferative disorders].
Leoni P; Sprovieri G; Recchioni A; Orrico C; Olivieri A
G Clin Med; 1983; 64(9-10):315-25. PubMed ID: 6363188
[No Abstract] [Full Text] [Related]
24. [Assay of serum beta 2-microglobulin in patients with malignant hematologic diseases and its clinical significance].
Zhong M; Liu W
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):277-8. PubMed ID: 9868137
[No Abstract] [Full Text] [Related]
25. Serial measurement of beta2 microglobulin, acute phase reactant proteins and the ESR in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
Cooper EH; Bunning R; Illingworth S; Späti B; Child JA
Biomedicine; 1978 Jul; 29(5):154-8. PubMed ID: 82455
[TBL] [Abstract][Full Text] [Related]
26. [Carcino-embryonic antigen and beta 2 microglobulin in malignant bone diseases. 61 cases (author's transl)].
Trèves R; Clément A; Desproges-Gotteron R; Olivier JP; Beck C
Nouv Presse Med; 1982 Jan; 11(1):21-4. PubMed ID: 6173840
[TBL] [Abstract][Full Text] [Related]
27. Beta 2-microglobulin in monoclonal gammopathies.
Vercelli D; Cozzolino F; Becucci A; Di Guglielmo R
Nouv Rev Fr Hematol (1978); 1982; 24(2):85-8. PubMed ID: 6180380
[No Abstract] [Full Text] [Related]
28. Serum beta 2-microglobulin in malignant lymphoma.
Hagberg H; Killander A; Simonsson B
Cancer; 1983 Jun; 51(12):2220-5. PubMed ID: 6189572
[TBL] [Abstract][Full Text] [Related]
29. High incidence of beta-2-microglobulin containing macromolecular complexes in sarcoidosis sera.
Falus A; Glikmann G; Svehag SE
Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):81-4. PubMed ID: 6191519
[TBL] [Abstract][Full Text] [Related]
30. beta 2 Microglobulin, a tumour marker of lymphoproliferative disorders.
Cassuto JP; Krebs BP; Viot G; Dujardin P; Masseyeff R
Lancet; 1978 Jul; 2(8080):108-9. PubMed ID: 78278
[No Abstract] [Full Text] [Related]
31. Hormonal changes in patients with haematological malignancies.
Pavelic K; Pekic B; Gabrilovac J; Bratic-Mikes V; Boranic M
Biomedicine; 1981 Nov; 35(6):181-4. PubMed ID: 6279194
[TBL] [Abstract][Full Text] [Related]
32. Association of serum beta 2-microglobulin with H-2 class I heavy chains on the surface of mouse cells in culture.
Kubota K
J Immunol; 1984 Dec; 133(6):3203-10. PubMed ID: 6436377
[TBL] [Abstract][Full Text] [Related]
33. Unexpected normal serum beta-microglobulin (B2M) levels in multiple myeloma.
Bataille R; Grenier J; Sany J
Anticancer Res; 1987; 7(3 Pt B):513-5. PubMed ID: 3307602
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma.
Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):3021-4. PubMed ID: 9329591
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of beta 2-microglobulin in human breast carcinoma.
Weiss MA; Michael JG; Pesce AJ; DiPersio L
Lab Invest; 1981 Jul; 45(1):46-57. PubMed ID: 6166789
[TBL] [Abstract][Full Text] [Related]
36. Correlation between tumor proliferation and serum levels of beta 2-microglobulin and thymidine kinase in malignant lymphomas.
Lehtinen T
Cancer Detect Prev; 1988; 12(1-6):125-31. PubMed ID: 3052829
[TBL] [Abstract][Full Text] [Related]
37. [A study of the significance of serum beta 2-microglobulin levels in patients with multiple myeloma--analyzes as a marker of renal dysfunction and as a marker of tumor cell mass].
Nishinarita S; Shimada H; Suzuki R; Kishigami Y; Sawada U; Horie T
Rinsho Ketsueki; 1996 Mar; 37(3):201-7. PubMed ID: 8727343
[TBL] [Abstract][Full Text] [Related]
38. [Serum beta-2 microglobulin in chronic lymphatic leukemia in relation to clinical staging].
Marques-Pereira JP; Montserrat E; Rozman C; Ballesta AM; Aguilar JL; Elena M
Sangre (Barc); 1982; 27(5):891-8. PubMed ID: 6188226
[No Abstract] [Full Text] [Related]
39. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
[TBL] [Abstract][Full Text] [Related]
40. [Effect of interferon on human cell lines which do not express class I transplantation antigens: K 562 and Daudi. Presence of a pseudo-messenger RNA of beta 2-microglobulin in Daudi cell line].
Rosa F; Fellous M
C R Seances Acad Sci III; 1982 Oct; 295(5):359-64. PubMed ID: 6185189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
